Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Kosan Biosciences Considers Mission Bay in SF
Kosan Biosciences may lease a two-story, 85,000-sf facility in San Francisco's Mission Bay. Developed by Catellus Development, the building stands adjacent to new University of California San Francisco facilities. Kosan, a Hayward, Calif.-based biotech firm that is alternately considering remaining in Hayward, has nearly 100 employees and a cancer compound in early clinical trials. Construction on the Mission Bay facility will begin in July 2002 if the lease is signed.
Gallo Clinic Seeks San Francisco Facility
The Ernest Gallo Clinic and Research Center is seeking up to 150,000 sf in San Francisco for its new home. The Emeryville, Calif.-based clinic has considered Catellus Development's Mission Bay and some south of Market locations. Proximity to research and funding collaborator UCSF is a factor in the possible relocation to San Francisco. The Gallo Clinic performs research in neuroscience, cell biology, molecular biology, pharmacology, and biochemistry, seeking genetic keys and therapies for alcohol and drug abuse.
Western Research Center Built for Biotech in Richmond
Simeon Properties is planning to redevelop the 86-acre former Zenica site in Richmond, Calif., to build the $100 million Western Research Center, a multi-phase biotech incubator. The first $50-million, 330,000-sf phase will involve demolishing six buildings, moving two existing buildings and building two additional facilities. The second phase will encompass 180,000 sf in two more buildings. A possible third phase, dependent on an entitlement from the City of Richmond and environmental remediation, would open up the remaining 55 acres.
Bayer Expansion Site Considered
Bayer is considering both Research Triangle Park and Kansas City, Mo., as potential expansion locations. RTP has offered the merged operations of Bayer and Aventis CropScience a strong package to locate its American headquarters in the Triangle. Bayer currently has manufacturing and toxicology facilities in Kansas City and employs 1300 workers in those facilities and in facilities across the Missouri River in Stilwell and Shawnee, Kan. The efficiency of having all functions centrally located in Kansas City could affect Bayer's decision.
GlaxoSmithKline Will Occupy New Gulph Mills Office Building
GlaxoSmithKline (GSK) plans to move 800 employees into a new five-story building under construction at the Renaissance Corporate Center, a 250-acre office park in Gulph Mills. Liberty Property Trust is building the $40-million, 200,000-sf build-to-suit, which is located across the street from the company’s other research and office operations. GSK is also considering expansion at its Upper Merion, Penn., location.